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Background: The expression of IFN- is under tight regulatory control.
Results: NF-B induces YY1 that negatively regulates TLR3-mediated expression of IFN-.
Conclusion: NF-B, via YY1, causes post-induction repression of IFN- expression in response to TLR3.
Significance: This is a novel regulatory mechanism for controlling IFN- expression.
The induction of -interferon (IFN-) is a key anti-viral
response to infection by RNA viruses. Virus-induced expression
of IFN- requires the co-operative action of the transcription
factors IRF-3/7, NF-B, and ATF-2/c-Jun on the IFN- pro-
moter leading to the orderly recruitment of chromatin remod-
eling complexes. Although viruses strongly activate NF-B and
promote its binding to the IFN- promoter, recent studies have
indicated that NF-B is not essential for virus-induced expres-
sion of IFN-. Herein, we examined the role of NF-B in regu-
lating IFN- expression in response to the viral-sensing Toll-
like receptor 3 (TLR3). Intriguingly pharmacological inhibition
of the NF-B pathway augments late phase expression of IFN-
expression in response to TLR3 stimulation. We show that the
negative effect of NF-B on IFN- expression is dependent on
the inductionof the transcriptional repressor proteinYinYang1.
We demonstrate that the TLR3 ligand polyriboinosinic:polyri-
bocytidylic acid (poly(I:C)) induces expression and nuclear
translocation of YinYang1 where it interacts with the IFN-
promoter and inhibits the binding of IRF7 to the latter. Evidence
is also presented showing that the NF-B subunits c-Rel and
RelB are the likely key drivers of these negative effects on IFN-
expression. These findings thus highlight for the first time a
novel self-regulatory mechanism that is employed by TLR3 to
limit the level and duration of IFN- expression.
Toll-like receptors (TLRs)3 are primary sensors of pathogen-
associated molecules that initiate innate immune reactions in
response tomicrobial challenge by activating transcription fac-
tors such as NF-B and inducing the expression of interferons
(IFNs) and proinflammatory cytokines (1). With the exception
of TLR3, all other mammalian TLRs employ the adaptor mye-
loid differentiation factor 88 (MyD88) as a key receptor proxi-
mal signaling molecule to stimulate downstream activation of
NF-B (2). In contrast, TLR3, which is liganded by dsRNA from
viral particles and the artificial ligand poly(I:C), interacts with a
different adaptor protein termed Toll-interleukin-1 receptor
domain-containing adaptor-inducing IFN- (TRIF) and trig-
gers differentiation factor 88-independent activation of NF-B
and the interferon regulatory factor (IRF) familymembers IRF3
and IRF7 (3). TRIF induces phosphorylation of IRF3/7 via two
kinases, TNF receptor-associated factor (TRAF) family mem-
ber-associated NF-B activator (TANK)-binding kinase 1
(TBK1) and inducible IB kinase (also known as IB kinase )
leading to nuclear translocation of IRF3/7 and their induction
of type I IFNs (1, 3). The latter are critical anti-viral molecules
that block viral replication (4, 5), and much effort has focused
on the mechanisms underlying virus-induced expression of
type I IFNs. The transcriptional regulation of the IFN- gene by
viruses has served as a paradigm in this regard (6, 7).
The enhancer region of the IFN- gene contains four positive
regulatory domains (PRDs). The coordinated binding of IRF3/7
to PRDI and -III, NF-B to PRDII, and ATF-2/c-Jun to PRDIV
leads to recruitment of co-activator proteins, resulting in
nucleosome acetylation and chromatin remodeling, ultimately
facilitating access of the transcriptionalmachinery to the IFN-
promoter (6, 8). Although IRF3 and IRF7 have been demon-
strated to play critical roles in enhancing transcription of IFN-
(9–11), the role of NF-B is less clear. Five subunits comprise
the NF-B family and are termed RelA (p65), RelB, c-Rel,
NF-B1 (p50 and its precursor p105), and NF-B2 (p52 and its
precursor p100) (12, 13). These subunits interact in various
dimeric combinations, with p50/p65 being most common.
Although p50 and p52 lack a transactivation domain, RelA,
RelB, and c-Rel each contain such a domain, and complexes
containing these latter subunits are capable of promoting gene
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transcription. In resting cells NF-B is sequestered in the cyto-
plasm via its association with members of the IB family, and
activation of the former requires prior phosphorylation of IBs
by IB kinases (14). Such phosphorylation facilitates subse-
quent polyubiquitination of IBs leading to their degradation
by the 26 S proteasome and allowing for nuclear translocation
ofNF-B (15). It is well known that viruses can strongly activate
thisNF-B pathway, with early studies demonstrating that viral
challenge can promote the binding of the NF-B subunits RelA
and p50 to the IFN- promoter leading to its activation (16, 17).
However, a more recent study usingmice deficient in the genes
encoding p50, RelA, or c-Rel demonstrated a nonessential role
for NF-B in mediating induction of IFN- in response to Sen-
dai virus or Newcastle disease virus infection (18). Instead, the
primary role for the NF-B subunits RelA appears to be in
maintaining low basal expression of IFN- before infection and
facilitating low level autocrine IFN- signaling in uninfected
cells (19, 20). In response to viral infection, NF-B is important
for early phase induction of IFN- when IRF activation is low,
but it fails to make a significant contribution to late phase peak
levels of IFN- when IRF proteins become the major drivers of
expression. Indeed, contrary to stimulating late phase expres-
sion of IFN- the recent studies, using NF-B-deficient mice
provide clues that NF-B may negatively regulate late phase
expression of IFN-. Thus dendritic cells from c-Rel/p50-defi-
cient mice produce higher levels of IFN- mRNA than wild
type cells in response to Sendai virus and Newcastle disease
virus (18), and RelA-deficient murine embryonic fibroblasts
(MEFs) show greater late phase expression of IFN- than wild-
type MEFs in response to Newcastle virus (19). This prompted
the present study in which we speculated that NF-B may play
a key role in post-induction repression of IFN-.
Although the IFN- promoter has served as a leading model
for defining our understanding of how transcription factors can
work together in a coordinated manner to promote eukaryotic
gene transcription, the mechanism underlying gene repression
at this promoter is less well understood. The protein Yin Yang 1
(YY1) is a transcription factor that, depending on cell type and
promoter context, can act as an activator or repressor of tran-
scription (21–23). YY1 binds to two sites on the murine IFN-
promoter and is capable of showing activation and repression of
this promoter (24). The occupancy of both the 90 and 122
sites of the IFN- promoter by YY1 leads to recruitment of the
histone acetyltransferase CBP (cAMP-response element-bind-
ing protein (CREB)-binding protein) and activation of the
IFN- promoter (25). In contrast, the repressor role of YY1 at
the IFN- promoter is mediated by its binding to the 90 site
and subsequent recruitment of a histone deacetylase that
represses the IFN-promoter (24). Given thatNF-Bpositively
regulates the expression of YY1 (26), we hypothesized that
NF-B may effect post-induction repression of IFN- via YY1.
We show that NF-B negatively regulates late phase expression
of IFN- in response to TLR3 stimulation and confirm a key
role for YY1 in mediating this inhibitory effect. The mechanis-
tic basis to this process is also presented. We show that TLR3
stimulation can promote increased expression of YY1 in a
NF-B-dependent manner most likely mediated by the c-Rel
and RelB subunit. TLR3 also promotes nuclear localization of
YY1 where it interacts with IFN- promoter and inhibits the
binding of IRF7 to the promoter. These findings thus define a
novelmechanismbywhich the viral-sensing receptorTLR3 can
employ NF-B to self-regulate the magnitude and duration of
IFN- expression.
EXPERIMENTAL PROCEDURES
Cell Culture and Reagents—HEK293 cells, stably expressing
TLR3, were from InvivoGen. Human U373 astrocytoma cells
stably transfected with CD14 (U373-CD14) and bone marrow-
derived macrophages (BMDMs) from wild type and TRIF-de-
ficient mice were gifts from Dr. Katherine Fitzgerald (Univer-
sity of Massachusetts Medical School). The HEK293 and
THP-1 cell lines were from the Health Protection Agency Cul-
ture Collection and were grown in DMEM and RPMI 1640,
respectively, with GlutaMAX (Invitrogen) supplemented with
10% fetal bovine serum, penicillin (100 g/ml), streptomycin
(100 g/ml), and Normocin (InvivoGen) (100 g/ml). Cells
were maintained at 37 °C in a humidified atmosphere of 5%
CO2. G418 (200 g/ml) was used to select for the stably trans-
fected TLR3 cell line and maintenance of CD14 expression.
Highly pure protein-free LPS derived from Escherichia coli
strain 011:B4 was from Alexis. Naked poly(I:C), a TLR3 activa-
tor, was from Invivogen. JSH-23 was from Calbiochem. The
rabbit anti-RelA (p65) antibody andmouse anti-c-Rel and anti-
YY1 antibodies were from Santa Cruz Biotech. The rabbit anti-
RelB antibody was fromNCI Biological Resources Branch. The
rabbit and anti-mouse Alexa Fluor 568 and anti-mouse Alexa
Fluor 633 secondary antibodies were from Invitrogen.
Expression Vectors/Recombinant Plasmids—The IFN- pro-
moter-, PRDI-III, PRDII-, and PRDIV-regulated firefly lucifer-
ase constructs were as described (3). pCMV YY1-HA plasmid
was a generous gift from Yang Shi (Harvard Medical School,
Boston, MA). The pcDNA expression constructs encoding
c-Rel-FLAG and RelB-FLAG were generous gifts from Gioac-
chino Natoli (European Institute of Oncology, Milan, Italy).
The pcDNA3.1 expression constructs encoding RelA-HA,
IRF3-FLAG, and IRF7-FLAG were cloned by standard proce-
dures in our laboratory.Murine YY1 lentiviral shRNAplasmids
were generous gifts from Mary E. Donohoe (Weill Cornell
Medical College) (27). Murine IRF7 shRNA lentiviral plasmids
were from Sigma (NM_016850).
First-strand cDNA Synthesis—BMDMs, U373, and THP-1
cells were seeded (3.5 105 cells/ml; 2 ml) in 6-well plates and
grown for 24 h. Cells were then stimulated with various ligands
for different times as indicated in the figures. Total RNA was
isolated from cells using the TRIzol reagent according to the
manufacturer’s instructions (Invitrogen). Isolated RNA (1 g)
was incubated with random hexamer primers (1l; 500g/ml)
at 70 °C for 5 min. Thereafter, the other reaction components
were added in the following order: 5 l of 5 RT buffer (Pro-
mega), 1.3 l of 10 mM dNTP, 0.7 l RNasin (Promega), 1 l of
Moloney murine leukemia virus reverse transcriptase (Pro-
mega), and nuclease-free water to a total volume of 25l. Reac-
tions were incubated at 37 °C for 40 min followed by 42 °C for
40 min and heating to 80 °C for 5 min. The first strand cDNA
was stored at20 °C for up to 1 month.
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Real-time PCR—Total cDNA was subjected to RT-PCR and
real-time quantitation with the DyNAmoHS SYBR Green
kit (Finnzymes) on a real-time PCR system (DNA Engine
OPTICON system;MJ Research). The following primers were
used to amplify the fragments of the indicated genes: mIFN-,
forward (GGAGATGACGGAGAAGATGC) and reverse,
(CCCAGTGCTGGAGAAATTGT); hIFN- forward, (AAC-
TGCAACCTTTCGAAGCC) and reverse (TGTCGCCTAC-
TACCTGTTGTGC);mTNF forward (CATCTTCTCAAA-
ATTCGAGTGACAA) and reverse (TGGGAGTAGACAA-
GGTACAACCC); hIL6, forward (AGCCACTCACCTCTT-
CAGAACGAA) and reverse (CAGTGCCTCTTTGCTGCT-
TTCACA); mYY1, forward (TCACCATGTGGTCCTCGG-
ATGAAA and reverse (TTCTGCCAGTTGCTTAGGGTC-
TGA). Each mRNA quantification was normalized relative
to the housekeeping gene hypoxanthine phosphoribosyl-
transferase 1 (HPRT) using the primers mHPRT forward
(CCCTGAAGTACTCATTATAGTCAAGGGCAT) and re-
verse (GCTTGCTGGTGAAAAGGACCTCTCGAAG), hHPRT
forward (AGCTTGCTGGTGAAAAGGAC) and reverse
(TATAGTCAAGGGCATATCC). Real-time PCR data were
analyzed using the 2CT method as previously described
(28).
Lentiviral Transduction—The plasmids encoding shRNA
constructs targeting mYY1 (mYY1 U6 shRNA) or mIRF7
(pLKO.1-puro IRF7) or their respective control plasmids (p5
U6 control shRNA and pLKO.1-puro Control Vector) were
integrated into lentiviral particles as previously described (29).
BMDMs (1 105 cells/well; 6-well plate) were transduced with
control shRNA,mYY, ormIRF7 shRNA lentiviral particles, and
cells were subsequently grown for 1 week under puromycin (10
g/ml) selection. The efficiency of YY1 and IRF7 knockdown
was assessed by RT-PCR using the following primers: mYY1,
forward (TCACCATGTGGTCCTCGGATGAAA) and reverse
(TTCTGCCAGTTGCTTAGGGTCTGA); mIRF7, forward
(TCAGGTTCTGCAGTACAGCCACAT) and reverse (ATG-
ATGGTCACATCCAGGAACCCA); mHPRT, forward (CCC-
TGAAGTACTCATTATAGTCAAGGGCAT) and reverse
(GCTTGCTGGTGAAAAGGACCTCTCGAAG).
siRNA Transfection—HEK293 or U373 cells were seeded in
12-well (1  105 cells/well) or 96-well (2  104 cells/well)
plates. Cells were allowed grow for 16 h and then transfected
with control or YY1-specific siRNA (20 nM) using Lipo-
fectamine 2000 as described by the manufacturer (Invitrogen).
After 36 h, efficiency of YY1 knockdown was assessed in U373
cells by Western blotting using a YY1-specifc antibody and in
HEK293 cells by semiquantitative RT-PCR.
Reporter Assays—HEK293, HEK293-TLR3, and HEK293-
TLR4 cells were seeded in 96-well plates (2 104 cells/well) and
grown overnight. Cells were co-transfected with the indicated
amounts of expression constructs encoding Trif, RelA-HA,
RelB-FLAG, c-Rel-FLAG, or YY1-HA and firefly luciferase
reporter constructs regulated by the IFN- promoter or the
PRDI/III, II, or IV domains (80 ng) using Lipofectamine as pre-
viously described (30). In all cases an expression construct
encoding constitutively expressed TK Renilla luciferase (40
ng) was cotransfected to normalize for transfection effi-
ciency. Cells were allowed to recover for 24 h after transfec-
tion and then stimulated with poly(I:C) or LPS as indicated.
Cell lysates were prepared, and reporter gene activity was
measured using the Dual Luciferase Assay system (Promega)
as described (30).
IRF7/RelA Nuclear Translocation Assay—U373 cells were
stimulated with poly(I:C) (10 g/ml) or LPS (100 ng/ml) for
0–2h.Cellswere centrifuged, and cell pelletswere resuspended
and incubated for 2 min on ice in 10 mM HEPES, pH 8.0, con-
taining 50 mM NaCl, 17% (w/v) sucrose, 1 mM EDTA, 0.4 mM
spermidine, 0.2% (v/v) Triton X-100, 0.8mMPMSF, 0.05% (v/v)
-mercaptoethanol, and 0.2 units/ml aprotinin. After centrifu-
gation at 12,000 g for 1min at 4 °C, the cell pellet was washed
with 10 mMHEPES, pH 8.0, containing 50 mMNaCl, 25% (w/v)
glycerol, 0.1 mM EDTA, 0.4 mM spermidine, 0.8 mM PMSF,
0.05% (v/v) -mercaptoethanol, and 0.2 units/ml aprotinin.
The supernatant was removed, and the nuclear pellet was
resuspended in 3 times the packed nuclear volume of ice-cold
10 mM HEPES, pH 8.0, containing 340 mM NaCl, 25% (w/v)
glycerol, 0.1 mM EDTA, 0.4 mM spermidine, 0.8 mM PMSF,
0.05% (v/v) -mercaptoethanol, and 0.2 units/ml aprotinin.
The samples were gently vortexed at 4 °C for 1 h and centri-
fuged at 12,000 g for 10min at 4 °C, and the supernatants (the
nuclear extracts) were saved. Nuclear extracts were normalized
for protein concentration and subjected to Western blotting
using anti-IRF7 and anti-RelA antibodies.
IFN- Enhancesome Pulldown Assay—HEK293-TLR3 cells
were seeded in 90-mm dishes (2  106 cells) and transiently
transfected using Lipofectamine 2000 (Invitrogen) with a
pCMV2 construct encoding YY1-HA and a pcDNA3.1 con-
struct encoding IRF7-FLAG (5 g). Corresponding empty vec-
tor constructs were used as controls. Cells were allowed to
recover for 24 h and then stimulated with poly(I:C) for various
times. Nuclear extracts were generated as previously described
(31). Nuclear extracts (250 g) were then incubated for 1 h at
20 °Cwith 3 nmol of biotinylated double-stranded oligonucleo-
tides corresponding to nucleotide sequences from the IFN-
enhanceosome. The sense strand has the sequence 5- CTAA-
AATGTAAATGACATAGGAAAACTGAAAGGGAGAAG-
TGAAAGTGGGAAATTCCTCTGAATAGAGAGGACC-3.
Streptavidin-magnetic beads (Invitrogen Dynabeads M-280)
were added to collect the biotinylated oligonucleotides and
associated proteins, and incubation was continued with a rota-
tion for 1 h at 4 °C.The beadswerewashed 3 timeswithwashing
buffer (5 mM Tris, pH 7.5, containing 0.5 mM EDTA, and 1 M
NaCl) and then subjected to Western blot analysis using an
anti-FLAG or anti-HA antibody.
Assay of IFN-—U373 cells were seeded in 12-well plates
(0.5  106 cells/well). Cells were then treated with or without
JSH-23 (30 M) for 1 h before stimulation with poly(I:C) (10
g/ml) for 16 h. Cell supernatants were collected and cleared
by centrifugation, and IFN- was assayed by sandwich
ELISA using rabbit anti-human IFN (Santa Cruz) as a cap-
ture antibody and biotinylated mouse anti-human IFN-
(Peprotech) in conjunction with streptavidin peroxidase as a
detection system.
Immunoblot Analysis—Cells were stimulatedwith poly(I:C) or
LPS as indicated, and lysates were subjected to SDS-PAGE fol-
lowed by Western blot analysis with an anti-phospho-(Thr180/
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Tyr182) p38 MAPK, anti-phospho-JNK (Thr-183/Tyr-185, Cell
Signaling), anti-IB (Cell Signaling), anti--actin (Sigma), anti-
FLAG (Sigma), or anti-HA (Cell Signaling) antibody.
ConfocalMicroscopy—U373 cells (1 106 cells perwell/6-well
plate) were stimulated with poly(I:C) (1 g/ml) for the indicated
times. Cells were then rinsedwith PBS, permeabilizedwithTriton
X-100 (0.2%v/v), and fixed at roomtemperature for 5minwith2%
(v/v) paraformaldehyde. Cells were then incubated overnight at
4 °C with rabbit anti-RelA (p65), rabbit anti-RelB, mouse anti-c-
Rel, or mouse anti-YY1 antibody (all at 1/50 dilution). Cells were
rinsed with PBS and incubated with the anti-rabbit or anti-mouse
Alexa Fluor 568 secondary antibody (1/200 dilution) or anti-
mouseAlexaFluor633 secondary antibody (1/200dilution) for 1h
in the dark with slow agitation. Cells were again washed with PBS
and counterstained using DAPI nuclear stain (Sigma). Fluores-
cencewas examined using anOlympus laser confocalmicroscope
(OlympusLifeandMaterial ScienceEurope,Hamburg,Germany).
Acquired imageswere analyzed using theOlympus FV 1.6b imag-
ing software. Negative control experiments were performed by
replacing the primary antibody with relevant IgG isotype controls
(Millipore) and using equal gain settings during acquisition and
analysis.
Chromatin Immunoprecipitation Assay—U373 cells were
grown to confluency in 6-well plates. Cells were pretreated for
30 min with or without JSH-23 (30 M) before stimulation for
4 hwith poly(I:C) (10g/ml). Chromatin immunoprecipitation
(ChIP) assays were performed essentially as previously
described (32) with some minor modifications. Briefly cells
were cross-linked with 1% (v/v) formaldehyde for 10 min at
37 °C. Isolated nuclei were subjected to three 15-s sonication
pulses using a Hielscher UP 200S sonicator at 50% of the total
power. This procedure yielded chromatin fragments of 200–
1000 bp. Chromatin preparations were precleared with protein
A/GPlus beads (SantaCruz Biotechnology) and then incubated
overnight at 4 °C with anti-YY1 or anti-IRF7 antibody (Santa
Cruz Biotechnology) or rabbit IgG. The immunoprecipitates
were then incubated with protein A/G-agarose beads (Santa
Cruz Biotechnology), washed, and collected for subsequent
reverse cross-linking by overnight incubation at 65 °C. DNA
was then extracted using phenol-chloroform and precipitated
in ethanol. Standard PCR was conducted with specific primers
designed to amplify the enhancesome region of the IFN- pro-
moter. The primers were forward (5-CTA AAA TGT AAA
TGACATAGG-3) and reverse (5-GGTCCTCTCTATTCA
GAG-3). PCR products were resolved by 2% (w/v) agarose gel
electrophoresis and then analyzed using a multiimager
Typhoon 8600 (Molecular Dynamics).
Data Analyses—Statistical analysis was carried out using the
unpaired Student’s t test using the SigmaPlot 2001 program. p
values of less than or equal to 0.05 were considered to indicate a
statistically significant difference where *, p 0.05 and **, p
0.01.
RESULTS
NF-B Negatively Regulates TLR3-induced Expression of
IFN-—To explore the potential of NF-B to mediate the
repression of IFN- after the activation of viral sensing TLRs,
BMDMs were pretreated in the absence or presence of the
NF-B inhibitor JSH-23 (33) before stimulation with the TLR3
agonist poly(I:C) and assaying of IFN- expression by quanti-
tative PCR. Poly(I:C) promoted strong induction of IFN-
expression in wild-type BMDMs, and this was strongly aug-
mented in cells pretreated with JSH-23 (Fig. 1A), suggesting
that NF-B can negatively regulate poly(I:C)-induced IFN-
expression. Poly(I:C) and JSH-23 failed to affect expression of
IFN- in TRIF-deficient BMDMs, indicating that under the
described experimental conditions both agents exert their
effects by regulating the TLR3 pathway. The positive effect of
JSH-23 on the TLR3 pathway shows specificity for IFN-
expression as JSH-3 failed to affect poly(I:C)-induced
expression of TNF (Fig. 1B). Furthermore the augmentation
of IFN- mRNA expression by JSH-23 shows selectivity for
TLR3 as LPS-induced expression of IFN- and TNF was
decreased by JSH-23 in BMDMs (Fig. 1,A and B). JSH-23 also
selectively augments poly(I:C)-induced expression of IFN-
in the human monocytic cell line THP-1 while failing to
affect poly(I:C) induction of TNF or LPS-induced expression
of IFN- and TNF (Fig. 1C). These findings indicate that the
negative regulatory effect of NF-B on TLR3-induced
expression of IFN- mRNA expression is not restricted to
murine BMDMs and instead is species- and cell-type inde-
pendent. In addition, JSH-23 also augments TLR3-induced
expression of IFN- protein (Fig. 1D), further validating the
above findings that were based on measuring levels of IFN-
mRNA. Furthermore, to confirm that these effects of JSH-23
on IFN- expression are associated with inhibition of
NF-B, cells were transfected with an expression construct
encoding IB super repressor protein and assessed for
effects on TLR3-induced expression of IFN-. Like JSH-23,
the IB super repressor protein augmented poly(I:C), but not
LPS-induced expression of IFN- (Fig. 1E), further validat-
ing the conclusion that activation of NF-B by TLR3 serves
as a mechanism to self-regulate its induction of IFN-.
YY1 Is Induced by NF-B and Negatively Regulates TLR3-
induced Expression of IFN-—To assess if the negative effect of
NF-B on TLR3-induced expression of IFN- is mediated by
direct inhibition of the IFN- promoter or indirectly by induc-
tion of a NF-B-induced repressor protein, BMDMs were
treated with the protein synthesis inhibitor cycloheximide and
examined for effects on poly(I:C)-induced expression of IFN-
mRNA. Like JSH-23, cycloheximide augmented the ability of
poly(I:C) to induce expression of IFN- mRNA (Fig. 2A),
whereas it failed to potentiate poly(I:C)-induced expression of
TNFmRNA (Fig. 2B) or LPS-induced expression of IFN- (Fig.
2A) and TNF mRNA (Fig. 2B). Furthermore, no synergy or
additive effects were observed when cells were co-treated with
JSH-23 and cycloheximide (Fig. 2A), suggesting that JSH-23
manifests its potentiating effects by blocking the induction of a
NF-B-regulated repressor protein.Given that YY1 is known to
be regulated by NF-B and can act as a repressor at the IFN-
promoter, we next probed the role of YY1 in poly(I:C)-medi-
ated IFN- induction. First, both poly(I:C) and LPSwere shown
to induce the expression of YY1 in BMDMs, and this expression
was reduced by pretreatment of cells with JSH-23 (Fig. 2C). The
role of YY1 in regulating TLR3- and -4-induced expression of
IFN- was then directly addressed by infecting BMDMs with
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lentiviral particles containing control or mYY1-specific
shRNA. The latter was shown to selectively and specifically
suppress endogenous expression of mYY1 as measured by
semiquantitative RT-PCR (inset, Fig. 2D). KnockdownofmYY1
resulted in strong augmentation of poly(I:C), but not LPS-in-
duced expression of IFN- mRNA (Fig. 2D), indicating a spe-
cific repressor role for mYY1 in regulating TLR3-induced
expression of IFN-. We next assessed whether the specific
effect of YY1 on IFN- mRNA also applies to human cells
and is cell type-independent. Thus human U373 cells were
transfected with control or YY1-specific siRNA to specifi-
cally suppress YY1 expression (inset, Fig. 2E). Poly(I:C)
showed greatly increased potential to induce IFN- in YY1-
knockdown cells relative to cells transfected with control
siRNA (Fig. 2E), further confirming a negative role for YY1 in
TLR3 signaling. To directly address whether YY1 mediates
the negative effects of NF-B on TLR3-induced expression
of IFN-, JSH-23 was examined for its effects on IFN-
expression in control and YY1-knockdown U373 cells. As
before, JSH-23 augmented poly(I:C)-induced expression of
IFN- mRNA in control cells, but notably potentiation was
no longer evident in YY1 knockdown cells (Fig. 2E), strongly
indicating that the positive effects of JSH-23 on IFN-
expression are mediated by negatively affecting the expres-
sion of NF-B-regulated YY1.
C-Rel and RelB Negatively Regulate TLR3-induced Expres-
sion of IFN-—Given that NF-B drives the expression of YY1
and negatively regulates IFN- expression in response to TLR3
stimulation, we next characterized the relative contribution of
each of the NF-B subunits containing a transactivation
domain to this process. We initially assessed the ability of
poly(I:C) to promote classical activation of NF-B in BMDMs,
as judged by degradation of the inhibitory protein IB. We
observed only modest degradation of IB in response to
poly(I:C), whereas LPS caused classical total depletion of IB
followed by its rapid resynthesis (Fig. 3A). In contrast, poly(I:C)
promoted strong activation of the p38 and JNK MAPK path-
ways, thus suggesting that even under conditions of strong
TLR3 signaling, this receptor is a poor activator of the classical
NF-B pathway. Using confocal microscopy, we next assessed
the ability of poly(I:C) to regulate the expression and nuclear
translocation of each of the transactivating NF-B subunits. In
unstimulated cells, the p65 subunit showed a predominant
cytoplasmic localization, and this was not affected by treatment
of cells with poly(I:C) (Fig. 3B). In contrast, poly(I:C) promoted
strong nuclear translocation of RelB (Fig. 3C) and c-Rel (Fig.
3D). The effects of each of these subunits on poly(I:C)-induced
activation of the IFN- promoter was next examined. Like YY1,
expression of c-Rel or RelB strongly inhibited poly(I:C)-induced
activation of the IFN- promoter, whereas overexpression of p65
augmented this response (Fig. 4A). To validate the functional con-
FIGURE 1. Inhibition of NF-B augments poly(I:C) induced expression of IFN-. Immortalized BMDMs from wild type (WT) and TRIF/mice (A and
B) and M-CSF-differentiated THP-1 cells (C) were treated with or without the NF-B inhibitor JSH-23 (30 M) for 30 min followed by further stimulation
in the absence or presence of poly(I:C) (1 g/ml) or LPS (10 ng/ml) for 2 h. E, U373 cells were previously transfected with an expression construct
encoding the IB super repressor (SR) protein or Renilla luciferase protein as control. Total RNA was isolated, converted to first-strand cDNA, and used
as a template for quantitative real-time RT-PCR to assay the mRNA expression levels of (A, C, and E) IFN- and (B and C) TNF. The levels of the relevant
mRNAs were normalized relative to the housekeeping gene HPRT and are expressed relative to normalized values from unstimulated cells. D, U373 cells
were treated with or without JSH-23 (30 M) for 1 h before stimulation with poly(I:C) (10 g/ml) for 16 h. Cell supernatants were subsequently assayed
for levels of IFN- protein by sandwich ELISA. All data represent the mean  S.E. of three independent experiments and were subjected to unpaired
Student’s t test, *, p  0.05; **, p  0.01.
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sequences of such effects on the IFN- promoter, the effects of
each of the subunits on TLR3-induced expression of IFN- pro-
tein was then assessed. In an analogous manner to the promoter
studies, whereas p65 potentiated poly(I:C)-induced expression of
IFN- protein, c-Rel andRelB inhibited this process (Fig. 4B). The
effects of the NF-B subunits on the expression levels of IFN-
proteinwere not as great inmagnitude as those seen on the IFN-
promoter, but it is important to note that the effects on the former
are limited by the degree of transfection efficiency. To further
probe the mechanistic basis to the differential effects of the Rel
subunits on the IFN-promoter, the sensitivity of eachof thePRD
regions of the IFN- promoter was then investigated. Both RelB
andc-Rel inhibitedactivationof thePRDI-IIIdomain (Fig. 4C) but
failed to regulatePRDII (Fig. 4D) orPRDIV(Fig. 4E),whereasRelA
showed a specific stimulatory effect on the NF-B-regulated
domain PRDII (Fig. 4D). Taken together, these findings suggest a
key role for the c-Rel and RelB subunits in the negative regulation
of TLR3-induced activation of the PRD I-III domain of the IFN-
promoter and expression of IFN-.
YY1 Negatively Regulates the PRDI/III Domains of IFN-
Promoter—We next focused on the potential mechanism(s) by
which YY1 may be used by the TLR3 pathway to self-regulate
IFN- expression. Initial studies used confocal microscopy to
characterize the ability of the TLR3 pathway to regulate cellular
expression and subcellular localization of endogenous YY1.
Although unstimulated U373 cells showed basal cytoplasmic
expression of YY1, poly(I:C) promoted a strong increase in the
expression of YY1with a predominant nuclear localization (Fig.
5A). Given the nuclear accumulation of YY1, we next addressed
the direct effects of YY1 on expression of IFN-. The expres-
sion of YY1 in U373 cells caused a strong inhibition of poly(I:
C)-induced expression of IFN- mRNA, whereas it failed to
affect IL-6 expression (Fig. 5B), indicating that YY1 can directly
and selectively regulate IFN- expression. This effect of YY1
expression is also specific as overexpression of a control protein
such as GFP fails to mimic the effects of YY1. To further probe
its mechanism of action, the regulatory effects of YY1 on the
IFN- promoter and the various regulatory domains were then
examined. Using the TLR3 adaptor Trif as a strong inducer of
the transfected IFN- promoter-regulated luciferase reporter
gene, co-expression of YY1 in HEK293 cells was shown to
strongly inhibit activation of the IFN- promoter (Fig. 5C). The
sensitivity of each of the PRD regions of the IFN- promoter
was also examined and, like RelB and c-Rel, YY1 strongly inhib-
ited activation of the PRD I-III domain but failed to regulate
PRDII or PRDIV. To further validate the finding that YY1 selec-
tively targets the PRDI-III regions, endogenous expression of
YY1 in HEK293 cells was suppressed by siRNA (inset, Fig. 5D),
and this resulted in augmented Trif-induced expression of the
luciferase reporter gene when the latter was regulated by the
FIGURE 2. NF-B negatively regulates TLR3-induced expression of IFN- via the induction of YY1. A–C, BMDMs were treated with or without the
NF-B inhibitor JSH-23 (30M) and/or cyclohexamide (Cycl., 10g/ml) for 30 min followed by further stimulation in the absence or presence of poly(I:C)
(1g/ml) or LPS (10 ng/ml) for 2 h (A and B) or 90min (C). Total RNAwas isolated, converted to first-strand cDNA, and used as a template for quantitative
RT-PCR to assay the mRNA expression levels of IFN- (A and B) and YY1 (C). The levels of the relevant mRNAs were normalized relative to the
housekeeping gene HPRT and are expressed relative to normalized values from unstimulated cells. D, BMDMswere transducedwith lentivirus-encoding
control or mYY1-specific shRNA. Cells were then stimulated with poly(I:C) (1 g/ml) or LPS (10 ng/ml) for 2 h. cDNA was generated and assayed for YY1
expression using semiquantitative PCR (inset) and for IFN- expression by quantitative RT-PCR as described above. E, U373 cells were transfected with
control (ctrl) or YY1-specific siRNA and allowed recover for 36 h. Cells were then treated with or without JSH-23 (30 M) for 30 min followed by further
stimulation in the absence or presence of poly(I:C) (1 g/ml) for 2 h. cDNA was generated and assayed for IFN- expression by quantitative RT-PCR. Cell
lysates were probed by Western blotting using an anti-YY1 antibody (inset). All data represent the mean S.E. of three independent experiments and
were subjected to unpaired Student’s t test. *, p  0.05; **, p  0.01.
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IFN- promoter or its PRDI-III region but not when controlled
by the PRDII and PRDIV domains (Fig. 5D). This provides
strong supporting evidence for YY1, like RelB and c-Rel, nega-
tively regulating activation of the IFN- promoter by targeting
its PRDI-III domains.
YY1 Inhibits Binding and Activation of IRF7 at IFN-
Promoter—Given that the transcription factors IRF3 and IRF7
bind to the PRDI/III regions of the IFN- promoter and pro-
mote its activation, YY1 was next assessed for its potential reg-
ulatory effects on IRF3 and IRF7. HEK293 cells were co-trans-
fectedwith low amounts of expression constructs encodingTrif
and IRF3 (Fig. 6A) and IRF7 (Fig. 6B), and these were shown
capable of inducing luciferase when regulated by IFN- pro-
moter or the PRDI-III region but not when regulated by PRDII
and PRDIV. Interestingly the co-expression of YY1 showed
only slight inhibition of the IFN- promoter and its PRDI-III
domains when driven by IRF3 (Fig. 6A), whereas it strongly
inhibited activation of these promoters when regulated by IRF7
(Fig. 6B). These data suggested that YY1 may selectively target
IRF7 at the IFN- promoter. However co-immunoprecipitation
analysis failed to show any interaction of YY1 with IRF3 or IRF7
(data not shown), thus excluding a direct association of YY1 with
IRF7 as an inhibitory mechanism. YY1 was thus examined for its
ability to directly bind to the IFN-promoter in response toTLR3
stimulation and to regulate IRF7 binding to the promoter under
these conditions. An oligonucleotide corresponding to the
enhancesome sequence from the IFN- promoter was used in
affinity precipitationof nuclear extracts frompoly(I:C)-stimulated
HEK293 cells previously transfected with expression constructs
encoding YY1 and IRF7. The purity of the nuclear extracts was
FIGURE3.TLR3 signalingactivatesRelBandc-Rel butnotRelA.A, BMDMswere treatedwithpoly(I:C) (1g/ml) or LPS (10ng/ml) for the indicated times. Cell
lysates were generated and assessed by Western blotting for levels of IB, phospho-JNK, phospho-p38 MAPK, and -actin. B–D, U373 cells were grown on
glass coverslips and treated with poly(I:C) (10g/ml) for 60 and 90min. Cells were fixed and probed for immunoreactivity with anti-RelA (B), anti-RelB (C), and
anti-cRel (D) antibodies. Immunoreactivitywas visualizedby confocalmicroscopyusing anAlexa Fluor 633-labeled secondary antibody.DAPI stainingof nuclei
is also included. Confocal images were captured using a Olympus FluoView FV1000 System laser scanning microscope equipped with the appropriate filter
sets. Data analysis was performed using the Olympus FV 1.6b imaging software. Individual cell images are shown for clarity, with the numbers in the overlay
panels indicating the frequency of the observed cellular localization in a population of cells within larger fields.
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demonstratedby thedetectionof high levels of thenuclear protein
histone H3 and barely detectable levels of the cytosolic protein
-tubulin (Fig. 6, C and D). Confirming the above findings from
confocal microscopy, poly(I:C) was again shown to promote
strong nuclear localization of YY1l and YY1 precipitated with the
enhancesome oligonucleotide (Fig. 6C), indicating that TLR3
stimulationcausesnuclear translocationofYY1, thusallowing it to
directly interact with the enhancesome sequence of the IFN-
promoter. Using this approach, poly(I:C) was shown to promote
strong nuclear translocation of IRF7 and its binding to the
enhancesome sequence (Fig. 6D). However the co-expression of
YY1, although failing to affect the nuclear translocation of IRF7,
reduced the TLR3-induced binding of IRF7 to the enhancesome
sequence. These data thus strongly suggest that YY1 negatively
regulates TLR3-induced expression of IFN- by inhibiting the
binding of IRF7 to the IFN- enhancesome. These findings sug-
gest amechanismwhereby the inductionofYY1byNF-B leads to
the binding of YY1 to the PRDI-III domain of the IFN-promoter
and thus the reduced binding of IRF7 to the promoter. To further
corroborate this hypothesis, U373 cells were treated with the
NF-B inhibitor JSH-23, subsequently stimulated with poly(I:C),
and then the in vivo binding of YY1 and IRF7 to the IFN- pro-
moter was assayed by chromatin immunoprecipitation. Poly(I:C)
promoted strong binding of YY1 to the IFN- promoter, and this
was considerably reduced by pretreatment of cells with JSH-23
(Fig. 6E). In contrast, poly(I:C) caused modest binding of IRF7 to
the IFN- promoter, but this was considerably enhanced by pre-
treatment of cells with JSH-23. This adds further support to our
proposal in which YY1 is regulated by NF-B and mediates post-
induction repression of IFN- by inhibiting the binding of IRF7 to
the IFN- promoter.
Given such clear importance of IRF7 as a target formediating
the inhibitory effects of YY1, it was next addressed if this under-
lying mechanism could explain the differential inhibitory
effects of YY1 on TLR3- and TLR4-induced expression of
IFN-. More specifically we evaluated the relative importance
of IRF7 in TLR3 and TLR4 signaling. Poly(I:C) and LPS were
initially compared for their abilities to activate IRF7. Poly(I:C)
promoted strong nuclear translocation of IRF7, whereas LPS
was ineffective even under conditions where the latter effected
strong translocation of RelA to the nucleus (Fig. 7A). This sug-
gested that poly(I:C) is a much stronger activator of IRF7 than
LPS, and this was further corroborated by the greater efficacy of
the former in inducing the expression of a luciferase reporter
gene regulated by the IRF7-responsive PRDI-III region of the
IFN- promoter (Fig. 7B). Again, the poly(I:C)-induced activa-
tion of the PRDI-III domain was sensitive to strong inhibition
by YY1, whereas the very modest activation by LPS was resis-
tant to inhibition by YY1. This is hardly surprising given that
LPS failed to promote the nuclear translocation of IRF7. These
findings implied a very important role for IRF7 in the TLR3 but
not TLR4 pathway. This was directly addressed by infecting
BMDMs with lentiviral particles containing control or IRF7-
specific shRNA. The latter was shown to selectively and specif-
ically suppress endogenous expression of IRF7 as measured by
semiquantitative RT-PCR (inset, Fig. 7C). Knockdown of IRF7
FIGURE 4.RelB and c-Rel negatively regulate TLR3-inducedexpressionof IFN-.A andC–E, HEK293-TLR3 cellswere cotransfectedwith plasmid constructs
encoding IFN- promoter (A)-, PRDI-III (C)-, PRDII (D)- or PRDIV (E)-regulated firefly luciferase (80 ng), constitutively expressed TK Renilla luciferase (20 ng), and
varying amounts (1, 10, and 20 ng) of expression constructs encoding RelA, c-Rel, RelB, and YY1. Cells were allowed recover for 16 h and then stimulated for 6 h
with poly(I:C) (1g/ml). Cell lysates were generated and assayed for firefly luciferase activity and normalized for transfection efficiency using Renilla luciferase
activity. Data are presented as -fold stimulation of firefly luciferase expression relative to unstimulated cells. B, U373 were grown on 12-well plates and
transfected with plasmid constructs encoding RelA, c-Rel, and RelB (300, 600, 900 ng). Cells were allowed recover for 16 h and then stimulated for 16 h with
poly(I:C) (1 g/ml). Cell supernatants were assayed for levels of IFN- protein by sandwich ELISA. Data represent the mean S.E. of triplicate determinations
from three independent experiments and were subjected to unpaired Student’s t test; *, p 0.05; **, p 0.01 relative to poly(I:C)-stimulated cells previously
transfected in the absence of the Rel expression constructs.
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resulted in strong inhibition of poly(I:C)- but not LPS-in-
duced expression of IFN- mRNA (Fig. 7C). These findings
clearly indicate that stimulation of the TLR3 pathway pro-
motes prominent nuclear translocation of IRF7 where it
strongly induces IFN- expression, whereas LPS is relatively
ineffective in activating IRF7, and thus IRF7 fails to play an
important role in mediating TLR4-induced expression of
IFN-. Given that YY1 targets IRF7, this provides the likely
mechanistic basis to the differential sensitivity of TLR3 and
TLR4 signaling to YY1.
DISCUSSION
Viral-induced expression of type I IFNs is a key anti-viral
response by the infected host. A signature of this response is
rapid induction of the type I IFNs followed by further amplifi-
cation of their expression through a feed-forward mechanism.
Although this is advantageous in clearing viral infections,
uncontrolled type I IFN expression can lead to autoimmune
diseases (34), and thus it is vitally important that the body is
equipped with mechanisms to repress IFN expression in the
post-induction phase. Herein, we describe findings that indi-
FIGURE 5. YY1 shows nuclear localization in response to TLR3 stimulation and negatively regulates the PRDI/III domains of the IFN- promoter.
A, U373 cells were grown on glass coverslips and treatedwith poly(I:C) (10g/ml) for varying times. Cells were fixed and probed for immunoreactivity with an
anti-YY1 antibody. Immunoreactivity was visualized by confocal microscopy using an Alexa Fluor 633-labeled secondary antibody. DAPI staining of nuclei is
also included. Confocal imageswere captured using aOlympus FluoView FV1000 System laser-scanningmicroscope equippedwith the appropriate filter sets.
Data analysis was performed using the Olympus FV 1.6b imaging software. Individual cell images are shown for clarity, with the numbers in the overlay panels
indicating the frequency of the observed cellular localization in a population of cells within larger fields. B, U373 cells were transfected with varying amounts
(300or 600ng) of expressionplasmid encodingYY1orGFP as a control. 24h after transfection, cellswere treatedwithpoly(I:C) (10g/ml) for 2 h. Total RNAwas
isolated, converted to first-strand cDNA, and used as a template for quantitative real-time RT-PCR to assay the mRNA expression levels of IFN- and IL-6. The
levels of themRNAs were normalized relative to the housekeeping gene HPRT and are expressed relative to normalized values from unstimulated cells. C and
D, HEK293-TLR3 cells were cotransfected with plasmid constructs encoding Trif (20 ng), YY1 (10, 20 ng), constitutively expressed TK Renilla luciferase (20 ng),
and IFN- promoter-, PRDI-III, PRDII-, or PRDIV-regulated firefly luciferase (80 ng). D, HEK293-TLR3 cells were also transfected with control and YY1-specific
siRNA.Cellswere allowed recover for 24h, andcell lysateswere thenassayed for firefly luciferase activity andnormalized for transfectionefficiencyusingRenilla
luciferase activity. Data are presented as -fold stimulation of firefly luciferase expression relative to cells transfectedwithout Trif but with an empty vector (EV)
construct. YY1 knockdownwas confirmed by generating cDNA and assaying varying dilutions for YY1 and HPRT expression using semiquantitative PCR (inset
in panel D). Data represent themean S.E. of triplicate determinations from three independent experiments andwere subjected to unpaired Student’s t test.
*, p 0.05; **, p 0.01. RLU, relative luciferase units.
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cate a novel self-regulatory mechanism employed by TLR3 in
controlling the levels of IFN- that are expressed in response to
TLR3 stimulation (Fig. 8). In this model a TLR3 ligand such as
poly(I:C) can activate the TRIF/TBK1/inducible IB kinase
pathway, leading to the binding of IRF7 to the IFN- promoter
and increased transcriptional activation of the IFN- gene.
Although TLR3 is a poor activator of the classical NF-B path-
way and especially p65, it can strongly activate other Rel sub-
units such as RelB and c-Rel, leading to induction of YY1. The
latter translocates to the nucleus where it displaces IRF7 from
the IFN- promoter, culminating in post-induction repression
of IFN-.
To date NF-B has been generally accepted to play a crucial
and indispensable role in driving strong IFN- expression.
However, more recent reports have questioned this dogma by
usingmice that are deficient in variousNF-B subunits to show
that NF-B is primarily involved in maintaining low basal
expression of IFN- and in the very early induction phase when
FIGURE 6. YY1 inhibits the binding and activation of IRF7 at the IFN- promoter. A and B, HEK293-TLR3 cells were cotransfected with plasmid
constructs encoding IRF3 (10 ng (A)) or IRF7 (10 ng (B)) and Trif (10 ng), YY1 (10, 20 ng), constitutively expressed TK Renilla luciferase (20 ng), and IFN-
promoter-, PRDI-III, PRDII-, or PRDIV-regulated firefly luciferase (80 ng). Cells were allowed recover for 24 h, and cell lysates were then assayed for firefly
luciferase activity and normalized for transfection efficiency using Renilla luciferase activity. Data are presented as -fold stimulation of firefly luciferase
expression relative to cells transfected without Trif. Data represent the mean  S.E. of triplicate determinations from three independent experiments
andwere subjected to unpaired Student’s t test. *, p 0.05; **, p 0.01. C and D, HEK293-TLR3 cells were transfectedwith expression plasmids encoding
HA-tagged YY1 with and without FLAG-tagged IRF7. Cells were allowed recover for 16 h and then stimulated with or without (control) poly(I:C) (10
g/ml) for the indicated times. Nuclear extracts were prepared and affinity-precipitated using streptavidin magnetic beads and a biotinylated oligo-
nucleotide corresponding to the enhancesome sequence from the IFN- promoter. Precipitations with magnetic beads in the absence of the oligonu-
cleotide served as a negative control for the assay. Nuclear extracts and enhancesome precipitates were subjected to Western blotting using anti--
tubulin, -histone H3, -HA, and -FLAG antibodies. The data are representative of two independent experiments. D, the levels of IRF7 in the enhancesome
precipitates were quantitated by densitometric analysis and are expressed relative to the levels of histone H3 in the corresponding nuclear extracts.
E, U373 cells were pretreated with or without JSH-23 (30 M) for 30 min and then stimulated in the absence or presence of poly(I:C) (10 g/ml) for 4 h.
Cells were fixed in formaldehyde followed by nuclei isolation and sonication. Sonicated nuclear lysates were immunoprecipitated with an anti-YY1 or
anti-IRF7 or rabbit IgG control antibody. Input DNA (before immunoprecipitation) and immunoprecipitated chromatin were analyzed by 20 or 35 cycles
of PCR, respectively, with primers designed to amplify a region of the IFN- promoter.
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IRF activation is still at a low level (18–20). In contrast to the
prevailing view, NF-B knock-out mice showed no defi-
ciency in overall expression levels of IFN- in response to
viral challenge, and indeed at later post-induction times lev-
els of IFN- were actually higher in the knock-out animals.
Although not discussed in the detail in the original reports,
these findings provided the first clues to us that NF-B may
repress IFN- expression. Herein, we employed a number of
independent approaches, including a pharmacological
inhibitor of NF-B and the IB super repressor protein to
explore the concept that NF-B may act as a post-induction
repressor of IFN- expression. Such independent ap-
proaches provide very strong corroborative support for
NF-B as an inhibitor of IFN- expression, and in the proc-
ess we also define the key role of YY1 in mediating such
repressor effects of NF-B.
Intriguingly, inhibition of the NF-B pathway augments
poly(I:C)-induced expression of IFN- while failing to affect
LPS-induced expression of this gene. This suggests that the
negative effects of NF-B on late phase expression of IFN-
show specificity for the TLR3 pathway. The underlying basis to
such selectivity is not due to any difference between the TLR3
and TLR4 pathways in inducing YY1 as both poly(I:C) and LPS
show comparable efficacy in promoting expression of YY1.
Instead, the differential effects appear to be due to the contrast-
ing roles of YY1 in TLR3 and TLR4 signaling. Thus, whereas
knockdown of YY1 augmented poly(I:C)-induced expression of
IFN-, no such effect was apparent in LPS-induced expression
FIGURE 7. IRF7mediates poly(I:C) but not LPS-induced expression of IFN-. A, U373 cells were treated with poly(I:C) (10g/ml) or LPS (100 ng/ml) for the
indicated times. Nuclear extracts were generated and assessed by Western blotting for levels of IRF7 and RelA. B, HEK293-TLR3 and HEK293-TLR4 cells were
cotransfected with plasmid constructs encoding PRDI-III-regulated firefly luciferase (80 ng), constitutively expressed TK Renilla luciferase (20 ng), and varying
amounts (1, 10, 20 ng) of expression constructs encoding YY1. Transfected HEK293-TLR3 and HEK293-TLR4 cells were allowed recover for 16 h and then
stimulated for 6h with poly(I:C) (1g/ml) or LPS (10 ng/ml), respectively. Cell lysates were generated and assayed for firefly luciferase activity and normalized
for transfection efficiency using Renilla luciferase activity. Data are presented as -fold stimulation of firefly luciferase expression relative to unstimulated cells.
C, BMDMswere transducedwith lentivirus encoding control or IRF7-specific shRNA. Cellswere then stimulatedwithpoly(I:C) (1g/ml) or LPS (10ng/ml) for 2 h.
cDNAwas generated and assayed for IRF7 andHPRT expression using semiquantitative PCR (inset) and for IFN- expression by quantitative RT-PCR. The levels
of IFN- expression are expressed relative to unstimulated (control) cells transduced with control shRNA.
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of IFN-. It was interesting to speculate that TLR3 signaling
may selectively regulate the ability of YY1 to act as a repressor
by controlling its localization. However, in the present studywe
show that poly(I:C) promotes strong nuclear localization of
newly synthesized YY1 (Fig. 4A), and the TLR4 ligand LPS can
similarly induce nuclear localization of YY1 (data not shown).
An alternative explanation for the differential effects of YY1
on TLR3 and TLR4 signaling lies in the relative importance
of NF-B and IRFs in driving IFN- expression. Whereas
NF-B is a critical mediator of TLR4-induced IFN- expres-
sion, our present findings in conjunction with data from
other reports (18, 19, 35) clearly show that NF-B plays a
relatively unimportant role in the TLR3 pathway, and
instead IRFs are the major driving forces that mediate TLR3-
induced expression of IFN-. Indeed we show that IRF7 is
strongly activated by TLR3 and plays an important media-
tory role in driving expression of IFN-. Furthermore, our
data show that IRF7 lacks functional importance in mediat-
ing TLR4-induced expression of IFN-. Given our findings
that YY1 targets IRF7, it is not surprising that YY1 shows
such prominent inhibitory effects on the TLR3 pathway
without affecting TLR4 signaling.
Although theTLR3 andTLR4 signaling pathways share some
downstream signaling components, the idea of certain mole-
cules differentially regulating the two pathways is not without
precedent. Thus, we and others have previously shown that the
adaptor molecule Mal negatively regulates TLR3 signaling
while acting as a positive mediator in the TLR4 pathway (30,
36). In addition we have also shown that the synthetic cannabi-
noid R()WIN55,212–2 can negatively regulate TLR4- but
augment TLR3-induced expression of IFN- (37). Further-
more, a previous report has shown that TLR4, but not TLR3,
requires the NF-B subunit, p65, to activate the interferon-
sensitive response element (35), and so it is not surprising that
NF-B can differentially regulate IFN- expression by TLR3
and TLR4.
It is interesting to note that although JSH-23 augments
TLR3-mediated induction of IFN-, this study shows that it
fails to regulate TLR3-induced expression of TNF. Indeed given
the role for NF-B in driving expression of TNF, it might have
been predicted that a NF-B inhibitor would instead inhibit
expression of TNF. Although our studies show that this cer-
tainly applies to TLR4-induced expression of TNF, the induc-
tion of the latter by TLR3 is refractory to inhibition by JSH-23.
This questions the role for NF-B as a transcriptional activator
of the TNF gene in the TLR3 signaling pathway, and this is
consistent with a report showing that inmacrophages TRIF can
FIGURE 8. Schematic representation of post-induction repression of IFN- expression by YY1 in TLR3 signaling pathway. TLR3 is engaged by a
dsRNA ligand (e.g. poly(I:C)) promoting activation of the TRIF/TBK1/inducible IB kinase pathway leading to the binding of IRF3 and IRF7 to the PRD I/III
domain of the IFN- promoter. This results in increased transcriptional activation of the IFN- gene. TLR3 is a poor activator of the classical NF-B
pathway and especially p65 but can strongly stimulate the nuclear translocation of the Rel subunits RelB and c-Rel followed by induction of YY1. The
latter translocates to the nucleus in response to TLR3 signaling, where it displaces IRF7 from the IFN- promoter resulting in post-induction repression
of IFN- expression.
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drive TNF induction by a mechanism independent of NF-B
(38).
The proposal of YY1 as a post-induction repressor of TLR3-
induced expression of IFN- is consistent with its regulation by
NF-B. In the present study we show that stimulation of TLR3
by poly(I:C) results in only very modest activation of the classi-
calNF-Bpathway, and instead theTLR3 pathway is associated
with activation of NF-B subunits, like RelB, that are more
associated with the non-classical pathway. Furthermore, the
latter pathway is also more likely to play a key leading role in
inducing YY1 and negatively regulating IFN- expression as
expression of RelB inhibits TLR3-induced activation of the
IFN- promoter and expression of the IFN- gene, whereas
overexpression of RelA, the subunit more closely associated
with classical activation of NF-B, augments TLR3-induced
expression of IFN-. This is consistent with a very recent study
showing that knockdown of RelB, but not RelA, inHT1080 cells
results in greatly augmented TLR3-induced expression of
IFN- (39). Thus, a model arises where RelA may play an
important role in the early phase induction of IFN- by TLR3,
and this is consistentwith previous studies usingRelA-deficient
mice (19, 20), whereas the present study suggests that NF-B
subunits like RelB play a more important role in mediating
post-induction repression of IFN-.
The post-induction repressor function of YY1 in the TLR3
pathway is also consistent with the ability of poly(I:C) to induce
YY1 and strongly promote its nuclear localization. In this
nuclear environment YY1 can exert its inhibitory effects on the
IFN- promoter. YY1 has been previously shown to suppress
basal activation of the IFN- promoter by recruiting histone
deacetylases (24). We now add to the molecular understanding
of how YY1 can repress the IFN- promoter by showing that
YY1 selectively targets the PRDI/III domain of the promoter by
inhibiting the binding of IRF7 to this domain. Thus, we propose
a model whereby stimulation of the TLR3 pathway can over-
come the basal suppressive effects of YY1 on the IFN- pro-
moter thus allowing for increased de novo transcription from
the promoter. This is facilitated by activation of transcription
factors such as RelA and IRF3 and IRF7. However, TLR3-in-
duced activation of the NF-B subunits c-Rel and RelB leads to
subsequent induction and nuclear translocation of YY1, result-
ing in reduced binding of IRF7 to the PRDI/III domain and thus
post-induction repression of IFN- expression.
It will be of interest to explore the role of YY1 in autoimmune
diseases that are associated with high expression levels of type I
IFNs. Indeed the regulation of YY1 expression may serve as a
valuable and novel therapeutic strategy in such cases. The
undoubted value of targeting YY1 to control IFN- expression
is best illustrated by Rift Valley fever virus. The nonstructural
protein NSs of this virus interacts with host proteins, including
YY1, and blocks the transcriptional activation of the IFN- pro-
moter, thus acting as the major virulence factor of Rift Valley
virus (40). The targeting of YY1 by a virus clearly highlights its
regulatory importance with respect to IFN- expression. We
now show that the induction of YY1 by NF-B acts as a physi-
ological braking system for TLR3-induced expression of IFN-.
This adds to our existing understanding of the complex regula-
tory network that controls activation of the IFN- promoter
and promotes YY1 as a lead target to exploit in efforts to design
new therapeutics to control autoimmune diseases associated
with dysregulated IFN- expression.
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